US 12391663
Isoindolinone compounds
granted A61PA61P35/00
Quick answer
US patent 12391663 (Isoindolinone compounds) held by Monte Rosa Therapeutics AG expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Monte Rosa Therapeutics AG
- Grant date
- Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P35/00